Weill Cornell Tetrathiomolybdate Study Results Presented at AACR

Dr Sarika Jain, a 3rd year Hematology Fellow at Weill Cornell Medical College, presented data on one of the Breast Center’s studies at the recent American¬† Association for Cancer Research (AACR) meeting.

The study presented was a Phase 2 trial of Tetrathiomolybdate in women with breast cancer at high risk of relapsing. The purpose of this study was to try to keep breast cancer cells in a dormant state by depleting copper, an essential component to helping these cells come out of dormancy.

The study data shows that the researchers were able to copper deplete patients safely with few side effects, and they were able to drive down the cells we believe are critical to facilitating metastases. Click here to read the abstract of the presentation.